Area of research
Molecular Biology · Complementary and alternative medicine
Research interest
Research interests include Phytochemicals and Medicinal Plants, Gut microbiota and health, Metabolism, Diabetes, and Cancer, and Adipokines, Inflammation, and Metabolic Diseases.
A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin Axes
Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
The Microbiome–Estrogen Connection and Breast Cancer Risk
Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
Honokiol inhibits epithelial—mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E‐cadherin axis
Integral Role of PTP1B in Adiponectin-Mediated Inhibition of Oncogenic Actions of Leptin in Breast Carcinogenesis
Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires β-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
Med1 plays a critical role in the development of tamoxifen resistance